Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 7.620 | ||
| Révision: | $879.12M | $928.74M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 10.100 | 9.400 | -0.7000 |
| Révision: | $958.37M | $1.06B | -$23.38M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 9.740 | 9.800 | 0.0600 |
| Révision: | $949.89M | $985.85M | -$7.43M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 9.970 | 10.190 | 0.2200 |
| Révision: | $1.00B | $978.39M | -$17.88M |
